Dr. Alexander Jonas Egusquiza, MD

Dr. Egusquiza practices at Miami Pulmonary Specialists in Miami, Florida.

Dr. Egusquiza's NPI, 1104276583, was assigned on June 16, 2016. Dr. Egusquiza graduated from University of Miami, Miller School of Medicine in 2012. Dr. Egusquiza holds Florida license ME161820.

Dr. Egusquiza's primary practice is Miami Pulmonary Specialists, at 7000 Sw 97th Ave, Miami, FL 33173 in Miami-Dade County. The practice phone is (786) 299-5419.

Dr. Egusquiza's primary practice is Miami Pulmonary Specialists in Miami, Florida. Dr. Egusquiza is also affiliated with Baptist Health Baptist Hospital. The medical group on file is Miami Pulmonary Specialists. Dmand AI also links Dr. Egusquiza to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Egusquiza practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Egusquiza's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Egusquiza is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Egusquiza's licenses on file in 3 states: Florida, California and Illinois.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), hypersomnia, pneumonia, pulmonary fibrosis, sleep apnea and tobacco use among the conditions Dr. Egusquiza treats.

CMS data shows 2,142 Medicare services from Dr. Egusquiza across 15 procedure codes in 2024, for 483 Medicare patients. Medicare paid $176,693 for them.

CMS counts 483 Medicare patients who saw Dr. Egusquiza in 2024. The largest group is 75 to 84, with 171 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 3.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Egusquiza's median patient age at 72, with 58% women.

In 2024, Dr. Egusquiza wrote 1,112 Medicare Part D claims for 241 patients. 54% of them were for generic drugs. CMS names the drug for 998 of them, across 17 drugs with 11 or more claims each, at $274,304 in total drug cost. In 2023, CMS named 243 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Egusquiza for performance year 2024, reported as part of a group. Dr. Egusquiza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Egusquiza as offering telehealth.

CMS Open Payments shows 252 general payments to Dr. Egusquiza from 29 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 99% of the total. GlaxoSmithKline, LLC. paid the most, $1,873.

Dr. Egusquiza graduated from University of Miami, Miller School of Medicine in 2012.

Dr. Egusquiza is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.